• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Epirus Biopharmaceuticals

edit

EPIRUS is focusing on the central development of a broad pipeline of biosimilar monoclonal antibodies and therapeutic proteins, optimized for use within the SCALE™ disposable manufacturing system, and designed to be deployed in an “In Market, For Market” ™ manufacturing configuration.

Recent Milestones

edit

• 
  Epirus Biopharmaceuticals added Amit Munshi as President and CEO. (5/1/12)
  Posted 1/29/13 at 3:50am
• 
  Epirus Biopharmaceuticals added Michael Wyand as Senior Vice President of Clinical and Regulatory.
  Posted 1/29/13 at 3:50am
• 
  Epirus Biopharmaceuticals added Nick Plumeridge as Senior Vice President of Business Development.
  Posted 1/29/13 at 3:50am

Videos

Screenshots

edit

Above: Epirus Biopharmaceuticals
Uploaded: 1/29/13

Sources